论文部分内容阅读
多发性骨髓瘤是血液系统常见的恶性肿瘤,由于其临床表现多种多样,很容易被误诊或漏诊,近年来随着诊疗水平和技术的进步,血液专科接诊的骨髓瘤患者明显增多,多发性骨髓瘤已经成为恶性血液肿瘤中最重要的病种之一,但由于该病患者以中老年人为主及目前治疗手段的局限,其长期缓解率、生存率并不乐观。针对骨髓瘤开展合理的个体化诊疗是血液科医生面临的重要挑战。我国目前针对骨髓瘤的诊断和治疗正逐渐与国际接轨,自体干细胞移植已成为高危骨髓瘤患者常规巩固治疗。国际上针对骨髓瘤的新药层出不穷,相
Multiple myeloma is a common malignant tumor of the blood system. Because of its diverse clinical manifestations, it is easily misdiagnosed or missed. In recent years, with the advancement of diagnosis and treatment and the advancement of technology, multiple myeloma patients have significantly increased myeloma, Sexual myeloma has become one of the most important diseases in malignant hematological malignancies. However, its long-term remission rate and survival rate are not optimistic due to the limitations of the elderly and the current treatment methods. Rational individualized diagnosis and treatment of myeloma is an important challenge for hematologists. At present, the diagnosis and treatment of myeloma in China is gradually becoming more and more in line with international standards. Autologous stem cell transplantation has become a routine consolidation therapy for patients with high-risk myeloma. International new drugs for myeloma after another, phase